can semaglutide cause colitis Ozempic and ulcerative colitis: Possible benefits and risks FDA Updates Ozempic Label to

Science 252 , 17081711 (1991)

doi:10.1016/j.cmet.2015.12.003

Investing in Health Equity | Why New York Should Cover FDA-Approved Anti-Obesity Medications Through Medicaid March 2026 New York faces an urgent challenge: without early, evidence-based intervention, todays obesity crisis will become tomorrows diabetes, cardiovascular disease, or disability crisis all leading to ballooned Medicaid expenditures

Gastrointestinal adverse effects were more commonly reported in the GLP-1 receptor agonist groups, while genital mycotic infections and volume depletion-related adverse effects were more frequently observed in the SGLT2 inhibitor groups